PHOT, CYTR, RNN & Extended Watchlist

Growlife, Inc. PHOT

We’re looking toward PHOT once again today, this old favorite of ours has provided us with opportinuties on countless occasions, and yesterday the company had some important news hit the wire. The company has enlisted the services of former Microsoft and Yahoo! exec, Marco Hegyi, to serve as Growlife’s President. The company is also set to begin a $40M capital infusion from a Nevada private investment group called CANX USA.

For these reasons, as well as the ripening conditions on the chart, we felt we needed to bring PHOT once again to the foreground of our discussions. We also prepared a video chart presentation for your convenience.

WOODLAND HILLS, Calif., Dec. 11, 2013 /PRNewswire via COMTEX/ — GrowLife, Inc. (OTCBB: PHOT), a diversified company operating in the legal cannabis industry which develops, markets and deploys products and services addressing the needs of legal cannabis growing and retail operations, including hydroponic growing equipment and retail support software, is pleased to announce that effective immediately, Marco Hegyi will assume the position of President and join the Board of Directors.


CytRx Corp. CYTR

CYTR put forth an exciting day of trading yesterday, with the stock undergoing several bounces. The stock opened at 3.90, and hit a subsequent high of 4.39 (+13%). We then saw a pullback to 3.45, and a bounce to 3.74 (+8%). This was followed by bounce from 3.55 to 4.02 (+13%), it pulled back again, and made another swing, this time from 3.60 to 4.05. (+13%)

Flippers certainly had the chance to have a field day with this one, with possible cumulative gains on the order of 47% presenting themselves.


Rexhan Pharmaceuticals, Inc. RNN

RNN came off of yesterday’s extended watchlist to provide our readers with a chance for a nice flip, trading from a low of .4026 to a high of .5179. That move represents an intraday gain of up to 29% on roughly 10X the posted 3mo. average volume.


Extended Watchlist:
OCLS, SNTA, BAXS, ASTC, AVNR
IMUC & SYN
– Big gap downs, looking for possible bounces